| |
| |
|
| Insider
Information: |
Crowley John F |
| Relationship: |
Director |
| City: |
Cranbury |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
590,194 |
|
|
Indirect Shares
|
97,759 |
|
|
| Direct
Value |
$6,348,212 |
|
|
|
Indirect Value
|
$688,536 |
|
|
| Total
Shares |
687,953 |
|
|
| Total
Value |
$7,036,748 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amicus Therapeutics Inc |
FOLD |
|
2024-03-01 |
573,478 |
2024-03-01 |
64,895 |
Premium* |
|
|
Intellia Therapeutics, Inc. |
NTLA |
Director |
2023-06-14 |
11,716 |
2021-06-23 |
0 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
Director |
2022-01-12 |
5,000 |
2022-01-12 |
32,864 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-03-01 |
4 |
S |
$13.35 |
$389,543 |
D/D |
(29,181) |
573,478 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-02-15 |
4 |
D |
$14.00 |
$1,329,566 |
D/D |
(94,969) |
602,659 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-02-15 |
4 |
S |
$13.81 |
$436,551 |
D/D |
(31,614) |
697,628 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-02-01 |
4 |
S |
$12.62 |
$398,918 |
D/D |
(31,614) |
750,838 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-02-01 |
4 |
D |
$12.67 |
$273,621 |
D/D |
(21,596) |
729,242 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-22 |
4 |
S |
$12.36 |
$683,958 |
D/D |
(55,327) |
782,452 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-16 |
4 |
S |
$12.78 |
$404,106 |
D/D |
(31,614) |
837,779 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-10 |
4 |
S |
$13.65 |
$431,452 |
D/D |
(31,614) |
869,393 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-10 |
4/A |
S |
$13.65 |
$431,452 |
D/D |
(31,614) |
927,013 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-09 |
4/A |
A |
$0.00 |
$0 |
D/D |
57,620 |
995,492 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-09 |
4/A |
D |
$13.65 |
$503,207 |
D/D |
(36,865) |
958,627 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-09 |
4 |
D |
$13.65 |
$503,207 |
D/D |
(36,865) |
901,007 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-04 |
4 |
D |
$13.44 |
$143,257 |
D/D |
(10,659) |
937,872 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-03 |
4 |
D |
$13.53 |
$1,466,882 |
D/D |
(108,417) |
948,531 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2024-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
144,628 |
1,056,948 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
34,572 |
912,320 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-12-15 |
4 |
S |
$12.66 |
$76,516 |
D/D |
(6,043) |
877,748 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-12-01 |
4 |
S |
$11.08 |
$66,956 |
D/D |
(6,043) |
883,791 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-11-15 |
4 |
S |
$10.84 |
$65,497 |
D/D |
(6,043) |
889,834 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-10-16 |
4 |
S |
$10.50 |
$63,449 |
D/D |
(6,044) |
901,921 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-10-02 |
4 |
S |
$11.08 |
$67,967 |
D/D |
(6,044) |
907,965 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-09-15 |
4 |
S |
$13.06 |
$78,964 |
D/D |
(6,044) |
914,009 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-09-01 |
4 |
S |
$12.98 |
$78,447 |
D/D |
(6,044) |
920,053 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-08-15 |
4 |
S |
$13.03 |
$78,734 |
D/D |
(6,044) |
926,097 |
0 |
- |
|
| FOLD |
Amicus Therapeutics Inc |
Executive Chairman |
• • – |
2023-08-01 |
4 |
S |
$13.35 |
$80,716 |
D/D |
(6,044) |
932,141 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
